Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Delivery
Return to: PBR Home | Drug Research | Drug Delivery | News
Search Refinements

Drug Delivery News

View news from other Pharmaceutical sectors:
46-60 of 2288 results
UK’s NICE supports restricted use of Alexion Pharmaceuticals' Strensiq
By PBR Staff Writer
The UK’s National Institute for Health and Care Excellence (NICE) has recommended the use of Alexion Pharmaceuticals’ Strensiq (asfotase alfa) drug to treat rare inherited bone disorder in children.
Drug Research > Drug Delivery > News
Facebook’s Mark Zuckerberg announces $3bn funding to help cure diseases
By PBR Staff Writer
Facebook CEO Mark Zuckerberg and his wife, Priscilla Chan, have committed to invest over $3bn during the next decade to work on preventing, curing or managing all diseases.
Drug Research > Drug Delivery > News
EMA validates BMS' type II variation application for Opdivo in advanced form of bladder cancer
The European Medicines Agency (EMA) validated Bristol-Myers Squibb's (BMS) type II variation application, which seeks to extend the current indications for Opdivo to include the treatment of locally advanced unresectable or metastatic urothelial carcinoma (mUC) in adults after failure of prior platinum-containing therapy.
Drug Research > Drug Delivery > News
Catalent agrees to buy Pharmatek Laboratories
By PBR Staff Writer
Drug delivery solutions provider Catalent has agreed to acquire Pharmatek Laboratories, a US-based contract drug development and clinical manufacturing firm, for an undisclosed sum.
Drug Research > Drug Delivery > News
ImmuPharma to open site in Mauritius for trial of Lupus treatment
ImmuPharma has provided a further update on the progress of its Phase III clinical trial of Lupuzor, its lead programme for the potential breakthrough compound for Lupus, the life threatening auto-immune disease.
Drug Research > Drug Delivery > News
Dr. Reddy's Laboratories launches Bupropion HCl extended-release tablets, USP (SR) in US
Dr. Reddy’s Laboratories has launched Bupropion HCl extended-release tablets, USP (SR) in 100 mg, 150 mg and 200 mg, a therapeutic equivalent generic version of Wellbutrin SR (bupropion HCl) Sustained-Release Tablets in the US market approved by the US Food & Drug Administration (USFDA).
Drug Research > Drug Delivery > News
Caisson Biotech seeks buyer for HEPtune drug-delivery platform
Caisson Biotech has appointed Pickwick Capital Partners to assist in the sale of the HEPtune drug-delivery platform.
Drug Research > Drug Delivery > News
Impax recalls one lot of Lamotrigine Orally Disintegrating Tablet 200 mg
Impax Laboratories has issued a voluntary nationwide retail level recall on August 19, 2016 for one lot of Lamotrigine Orally Disintegrating Tablet (ODT) 200 mg.
Drug Research > Drug Delivery > News
Marken secures new pharmaceutical license for Moscow depot
Marken has secured a new pharmaceutical license from the Russian Federation for its Moscow depot.
Drug Research > Drug Delivery > News
Supernus secures FDA tentative approval for expanded label of Trokendi XR
The US Food and Drug Administration (FDA) has granted tentative approval to Supernus Pharmaceuticals' Supplemental New Drug Application (sNDA) requesting a label expansion for Trokendi XR to include prophylaxis of migraine headache in adults.
Drug Research > Drug Delivery > News
Tissue Regeneration engineered mesenchymal stromal cells advance monoclonal antibody therapy
Tissue Regeneration Therapeutics announced that a team of Canadian researchers has for the first time shown that TRT's engineered mesenchymal stromal cell product (eTXP) can be used to deliver therapeutically useful monoclonal antibodies (mAbs) more effectively than administration of the mAbs themselves.
Drug Research > Drug Delivery > News
Molecular flexibility demonstrated to help pharmaceutical drugs bind to their targets
Scientists have discovered an alternative way to create a stronger binding between pharmaceutical drugs and the part of the body they are targeting – a development that can be used to fight a variety of diseases, including breast cancer.
Drug Research > Drug Delivery > News
Nymox unveils major progress in evidence for efficacy of prostate drug
Nymox Pharmaceutical has announced major progress in the evidence for the safety and efficacy of fexapotide, the Company's Phase 3 drug in the final stages of development for prostate enlargement (BPH) and for low grade prostate cancer.
Drug Research > Drug Delivery > News
Valeant Pharmaceuticals relaunches generic ofloxacin otic solution
Valeant Pharmaceuticals International has relaunched its generic ofloxacin otic solution to treat bacterial ear infections.
Drug Research > Drug Delivery > News
Teva launches generic Gleevec tablets in US
Teva Pharmaceutical Industries has launched the generic equivalent to Gleevec1(imatinib mesylate) tablets,100 mg and 400 mg, in the US for multiple indications approved by the FDA.
Drug Research > Drug Delivery > News
46-60 of 2288 results